Republican lawmakers are once again pushing legislation that would require Kentucky to conduct a clinical study on using psilocybin, more commonly referred to as “magic mushrooms,” to treat depression, substance use or as part end-of-life care. Last year, the House...
Federal courts and regulatory bodies are showing a keen interest in upholding federal employment laws within the marijuana industry; despite the federal classification of cannabis as a Schedule 1 substance under the Controlled Substance Act (CSA). In such instances,...
BDSA, provider of the most accurate and comprehensive retail sales data for the cannabis industry, today announced an enhancement to its Menu Analytics solution that introduces daily insights into pricing, availability and markup. The launch of daily Menu Analytics...
